Somebody wagering pocket change on a timely acceptance? Their pockets are deeper than mine!
It would be a bit perverse to ask for an Adcon or slide the date with only three days left now - but who knows with the FDA?
Not sure we should get too focused on that day, since the FDa could mandate an extension or set an Adcon date sometime later; either way the approval process takes longer.
You should hope they will need more funds - to further develop the ADT product line - won't need funds if that fizzles. More to the point is just how much they will need.
closer to 810M if not mistaken - somebody have the precise figure?
Issuance seems to have slowed somewhat, with fewer shares being sold to Lincoln Park and elsewhere, but will likely continue until debt can be incurred as an attractive alternative, since earnings are not yet available and probably won't be for some time. Many are hoping for a buyout or even rumblings of a potential buyout to bump the PPS.
Latest I saw was around 90 % - but with expedited review and filing fee waiver, I would think the odds are better. Any data or thoughts?